What Can You Expect?
Celebrating its 16th edition, the World Bispecific Summit remains the premier industry-focused forum dedicated exclusively to bispecific and multispecific drug development.
From unprecedented clinical success in VEGF/PD-1 combinations to the expanding application of bispecifics in autoimmune diseases, 2024 saw significant progress, fueled by a surge in investment, competition, and scientific curiosity around how bispecifics can unlock next-generation therapies. To ensure this momentum continues, 2025 marks a critical year to sharpen strategies across bi- and multi-specific design, immune biology, translational modelling, and clinical differentiation.
Unmissable 2025 Highlights from the Brightest Minds in Bispecific Development:
With 100+ bispecific developers, scientists, and strategists in the room, this is your opportunity to exchange data, ideas, and solutions with those leading the next generation of bispecific innovation.
Decoding the success of PD-1xVEGF and PD-L1xVEGF bispecifics to understand what drives better efficacy and tolerability, and what it means for future target combinations.
Advancing next-gen TCEs and bsADCs with enhanced tumor specificity, synapse formation, and solid tumor penetration.
Translating bispecifics into autoimmunity with lessons from cytokine, checkpoint, and co-stimulatory biology, alongside conditionally active formats and immune-tuning strategies.
Engineering tri- and tetraspecifics, masked antibodies, and protease-cleavable linkers for selective activation and reduced off-target effects.
Aligning target selection frameworks with immune mechanisms and disease biology to improve predictability and clinical translation.
Explore the Full Event Guide
- 25+ World-Class Speakers
- Days of Exclusive Insights into Bispecific & Multispecific Antibody Drug Development
- Exclusive Networking & Partnering Opportunities
- Focused Industry-Led Community of Top Bispecific & Multispecific Biopharma
Explore the Agenda
Uncover the latest advances in bispecific development, from novel PD-1/VEGF breakthroughs to emerging autoimmune applications. Gain exclusive insights into target selection, translational hurdles, and clinical strategy through expert-led panels and interactive roundtable discussions.
Partner With Us
Align your brand with industry leaders driving the future of Bispecifics. Showcase your expertise and connect with senior decision-makers actively seeking innovative discovery, development, and manufacturing solutions.
Join Biopharma Experts
Engage in high-impact discussions with peers across discovery, preclinical, translational, and clinical development. Build meaningful relationships and explore strategic opportunities through structured and informal networking sessions.